SLC11A2: a promising biomarker and therapeutic target in ovarian cancerLiming Tian, Guofen Yang, Xuemei Li et al.|Scientific Reports|2023Cited by 15
Pre-existing cancer cells and induced fibroblasts are key cells for early chemoresistance in ovarian cancerLangyu Gu, Guofen Yang, Yang Zhang et al.|medRxiv|2024Cited by 1